# Jennison Associates: portfolio, investments and team > Jennison Associates is a growth equity based in United States. 17 investments on record, latest Aug 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/jennison-associates (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Jennison Associates Last cheque observed Aug 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Growth equity Seed Series A Series B Mobile Wireless Cheques on record **0%** of best year **0** **cheques in 12 months**, 17 on record Since the last cheque **4081** days **00** hrs **00** min **00** sec Median round **$65M** Rounds led **0 of 17** Exits **2 from the portfolio** Mostly in **United States, 94%** Pitch Jennison Associates ## Jennison Associates highlights - 01 17 rounds on record - 02 Mostly Series B and Series C: 65% of its rounds - 03 2 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Mobile Wireless - **Based in:** New York, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **17 appearances** - **2015** 10 rounds - **Aug** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series C · US **$80M** With 12 others - **Aug** **[Wave Life Sciences](https://millionrounds.com/company/wave-life-sciences)** Series B · US **$66M** With 6 others - **Aug** **[Ovid Therapeutics](https://millionrounds.com/company/ovid-therapeutics)** Series B · US **$75M** With 7 others - **Aug** **[Editas Medicine](https://millionrounds.com/company/editas-medicine)** Series B · US **$120M** With 14 others - **Jul** **[GenSight Biologics](https://millionrounds.com/company/gensight-biologics)** Series B · FR **$36M** With 8 others - **Jul** **[Afferent Pharmaceuticals](https://millionrounds.com/company/afferent-pharmaceuticals)** Series C · US **$55M** With 5 others - **Jun** **[UNUM Therapeutics](https://millionrounds.com/company/unum-therapeutics)** Series B · US **$65M** With 11 others - **May** **[REGENXBIO](https://millionrounds.com/company/regenxbio)** Series D · US **$71M** With 12 others - **Apr** **[Dimension Therapeutics](https://millionrounds.com/company/dimension-therapeutics)** Series B · US **$65M** With 7 others - **Apr** **[Natera](https://millionrounds.com/company/natera)** Series F · US **$56M** With 6 others - **2014** 4 rounds - **Nov** **[Nivalis Therapeutics](https://millionrounds.com/company/nivalis-therapeutics)** Series B · US **$30M** With 4 others - **Sept** **[Flex Pharma](https://millionrounds.com/company/flex-pharma)** Venture · US **$40M** With 9 others - **Aug** **[Bellicum Pharmaceuticals](https://millionrounds.com/company/bellicum-pharmaceuticals)** Series C · US **$94M** With 7 others - **Apr** **[Otonomy](https://millionrounds.com/company/otonomy)** Series D · US **$49M** With 11 others - **2013** 1 round - **Mar** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Growth · US · finsmes.com **$60M** With 8 others - **2011** 1 round - **Apr** **[Merrimack Pharmaceuticals](https://millionrounds.com/company/merrimack-pharmaceuticals)** Growth · US · fiercebiotech.com **$77M** With 6 others - **2006** 1 round - **Aug** **[ChemoCentryx](https://millionrounds.com/company/chemocentryx)** Series C · US · chemocentryx.com **$18M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **10 named** DA **David Alexander Hunt** Director i Form ADV HA **Heather Amy Kaden** Managing Director & Chief Compliance Officer i Form ADV JV **Janice Vrdoljak** Managing Director & Chief Financial Officer i Form ADV JT **Jeffrey Todd Becker** Chairman, Director & Chief Executive Officer i Form ADV JM **Jurgen Muhlhauser** Director i Form ADV KA **Kathleen Ann Mccarragher** Managing Director, Head of Growth Equity & Director i Form ADV KM **Kenneth Moore** Executive Vice President, Treasurer, Chief Operating Officer & Director i Form ADV MM **Mirry Melissa Hwang** Managing Director, Secretary & Chief Legal Officer i Form ADV PM **Pamela Margaret Sinclair** Director i Form ADV TH **Taimur Hyat** Director i Form ADV We also hold **29** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$215B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Jennison Associates LLC - **SEC number:** CRD 107959 Funds on its Form ADV **8** private funds, **$5.7B** in gross assets · filed Dec 2024 Trust company collective inv **6** Hedge **2** - Invesco Fixed Income Trust Jennison Intermediate Fund *Trust company collective inv* 2 investors $4.4B - Jennison Growth Equity Fund of the Prudential Trust Company Institutional Business Trust *Trust company collective inv* 6 investors $409M - Jennison Global Opportunity Fund of the Prudential Trust Company Institutional Business Trust *Trust company collective inv* 11 investors $358M - Jenop Global Healthcare Fund Limited *Hedge* 43 investors $252M - Jennison Global Healthcare Master Fund, LTD. *Hedge* 29 investors $216M - Jennison U.S. Small CAP Equity Fund of the Prudential Trust Company Institutional Business Trust *Trust company collective inv* 3 investors $50M - Jennison Christian SRI Small/Mid CAP Core Equity Fund of the Prudential Trust Company Institutional Business Trust *Trust company collective inv* 2 investors $26M - Jennison Small/Mid CAP Fund of the Prudential Trust Company Institutional Business Trust *Trust company collective inv* 1 investor $6.8M ## Exits from the portfolio Companies it backed that were later bought or listed **2 in all** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Listed **$125M** Jun 2013 **[Merrimack Pharmaceuticals](https://millionrounds.com/company/merrimack-pharmaceuticals)** Listed **Undisclosed** Mar 2012 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Seed Series A Series B Median round joined **$65M** the round, not its cheque Led 0 of 17 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Aug 2015 - **Exits:** 2 from the portfolio Rounds by stage said on their site - Series B said *7* - Series C *4* - Growth said *2* - Series D *2* - Series F *1* - Venture *1* - Seed said *-* Cheques by year Led Joined 2006 2015 Often in the room with - [Fidelity Management and Research Company](https://millionrounds.com/fund/fidelity-management-and-research-company) 5 - [OrbiMed](https://millionrounds.com/fund/orbimed) 5 - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 5 - [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 4 - [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) 4 - [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) 4 **Pitching Jennison Associates?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Jennison Associates. A count of rooms they were both in, not a relationship either has claimed. [**Fidelity Management and Research Company** Growth equity **5** rounds together](https://millionrounds.com/fund/fidelity-management-and-research-company)[**OrbiMed** Private equity **5** rounds together](https://millionrounds.com/fund/orbimed)[**RA Capital Management** Private equity **5** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Cormorant Asset Management** Private equity **4** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**New Leaf Venture Partners** VC firm **4** rounds together](https://millionrounds.com/fund/new-leaf-venture-partners)[**Perceptive Advisors** Asset manager **4** rounds together](https://millionrounds.com/fund/perceptive-advisors)[**Redmile Group** VC firm **4** rounds together](https://millionrounds.com/fund/redmile-group)[**EcoR1 Capital** Private equity **3** rounds together](https://millionrounds.com/fund/ecor1-capital)[**F-Prime Capital** VC firm **3** rounds together](https://millionrounds.com/fund/f-prime)[**Sabby Capital** Private equity **3** rounds together](https://millionrounds.com/fund/sabby-capital)[**Brookside Capital** Hedge fund **2** rounds together](https://millionrounds.com/fund/brookside-capital)[**Credit Suisse** VC firm **2** rounds together](https://millionrounds.com/fund/credit-suisse) ## Mentioned on podcasts Episodes that name Jennison Associates in their description, not their title. - [The Twenty Minute VC](https://millionrounds.com/podcasts/20vc) 14 Nov 2022 · 47 min 20VC: ARK Invest's Cathie Wood on Why ARK Has Not Had More Outflows Despite Performance, How the Global Tech Equities Market Will Go From $7Trn to $210Trn in 8-10 Years, The Future for Facebook and How Elon Musk and Jack Dorsey Could Create the Biggest Di Mentions [Elon Musk](https://millionrounds.com/fund/elon-musk)[Jack Dorsey](https://millionrounds.com/fund/jack-dorsey)[Jennison Associates](https://millionrounds.com/fund/jennison-associates) Apple PodcastsShow page - [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 15 Mar 2021 · 1h 5m Crypto for Institutions 3: Seth Ginns – Investing Beyond Bitcoin (Capital Allocators, EP.182) With [Seth Ginns](https://millionrounds.com/person/seth-ginns) Mentions [Google](https://millionrounds.com/fund/google-assistant-investments)[Jennison Associates](https://millionrounds.com/fund/jennison-associates) Apple PodcastsShow page ## Quick answers about Jennison Associates ### What does Jennison Associates invest in? Jennison Associates invests most often at Series B and Series C (65% of the rounds on record), in sectors such as Mobile and Wireless. ### How active is Jennison Associates? 17 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2015. ### How big are Jennison Associates's cheques? The median round it joins is $65M. ### Does Jennison Associates lead rounds? Rarely, if at all: none of its 17 investments on record names it as the lead. ### Where does Jennison Associates invest? Most of the companies it backs are in the United States (94%) and France (6%). ### Is Jennison Associates investing now? No investments in the last 12 months; the latest was in Aug 2015. ### Who does Jennison Associates invest alongside? Most often Fidelity Management and Research Company (5 rounds together), OrbiMed (5 rounds together) and RA Capital Management (5 rounds together). ### What kind of investor is Jennison Associates? Jennison Associates is a growth equity firm based in New York, United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=jennison-associates) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=jennison-associates)